Hepatoprotective Effects of Ginseng Intestinal Metabolite IH-901 on Chemical-Induced Hepatic Damage

  • Published : 2005.08.30

Abstract

Hepatoprotective effects of white ginseng extract (WGE), and IH-901 (20-O-${\beta}$-D-glucopyranosyl-20(S)-protopanaxadiol) derived from intestinal metabolite of ginsenoside $Rb_1$ were studied using two experimental animal models with chemical-induced hepatic damage. Administration of WGE (200 and 500 mg/kg) and IH-901 (0.01, 0.05, and 0.1 mM/kg) significantly decreased aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in acute hepatitic mice induced by $CCl_4$. Administration of WGE (l00 mg/kg) and IH-901 (0.02, 0.04, and 0.08 mM/kg) significantly decreased AST and ALT levels in acute hepatitic rats induced by D-galactosamine. AST and ALT levels of IH-901 groups decreased. These results suggested WGE and IH-901 may have protective effects against chemical-induced hepatic damage.

Keywords

References

  1. The encyclopedia of Wakan-Yaku with color pictures (I) Namba, T.
  2. Can. J. Comp. Med. v.45 Effect of ether, ethanol and aqueous extracts of ginseng on cardiovascular function in dogs Lee, D.C.;Lee, M.O.;Kim, C.Y.;Clifford, D.H.
  3. Agents Actions. v.15 Immunomodulatory effects of Panax ginseng C. A. Meyer in the mouse Jie, Y.H.;Cammisuli, S.;Baggiolini, M.
  4. Korean J. Ginseng Sci. v.20 Recent studies on the chemical constituents of Korean ginseng Park, J.D.
  5. Hanguk Saenghwa Hakhoe Chi. v.10 Biochemical studies of ginseng saponins. XI. The effects of ginseng saponins on aldehydrogenase Joo, C.N.;Koo, J.D.;Kim, D.S.;Lee, S.J.
  6. Wakan Yaku Gakkaishi. v.2 Action of ginsenosides on tumor cells. 1. Growth inhibition and redifferentiation of neoplasia Tahara, M.;Kono, H.;Mune, S.;Odashima, S.
  7. Chem. Pharm. Bull. v.33 Studies on the mechanism of the hypoglycemic activity of $ginsenoside-Rb_2$ in streptozotocin-diabetic rats Yokozawa, T.;Kobayashi, T.;Oura, H.;Kawashima, Y.
  8. Chem. Pharm. Bull. v.22 Studies on the saponins of ginseng. I. Structure of $ginseng-R_0,\;Rb_1,\;Rb_2,$ Rc and Rd Sanata, S.;Kondo, N.;Shoji, J.;Tanaka, O.;Shibata, S.
  9. Yakugaku Zasshi. v.107 Chemical studies on crude drug processing. V. On the constituents of ginseng radix rubra (2) : Comparison of the constituents of white ginseng and red ginseng prepared from the same Panax ginseng root Kitagawa, I.;Taniyama, T.;Shibuya, H.;Nota, T.;Yoshikawa, M.
  10. Planta Med. v.62 Main ginseng saponin metabolites formed by intestinal bacteria Hasegawa, H.;Sung, J.H.;Matsumiya, S.;Uchiyama, M.
  11. Planta Med. v.63 Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins Hasegawa, H.;Sung, J.H.;Benno, Y.
  12. Planta Med. v.57 Anti-hepatitic activity of ginsenoside Ro Matsuda, H.;Samukawa, K.;Kubo, M.
  13. Clin. Chem. v.21 Effects of drugs on clinical laboratory tests Young, D.S.;Pestaner, L.C.;Gibberman, V.
  14. Eur. J. Pharmacol. v.368 Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin Kiichiro, K.;Seiichi, K.;Hirohide, H.;Hiroko, M.;Hiroyuki, M.;Yoshio, K.
  15. FEMS. Immunol. Med. Microbiol. v.31 Flavonoids protect mice from two types of lethal shock induced by endotoxin Takahashi, K.;Morikawa, A.;Kato, Y.;Sugiyama, T.;Koide, N.;Mu, M.M.;Yoshida, T.;Yokochi, T.
  16. Planta Med. v.68 Hepatoprotective effect of majonoside R2, the major saponin from Vietnamese ginseng Tran, Q.L.;Adnyana, I.K.;Tezuka, Y.;Harimaya, Y.;Saiki, I.;Kurashige, Y.;Tran, Q.K.;Kadota, S.